AlzChem Group AG/€ACT
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About AlzChem Group AG
AlzChem Group AG operates within the chemical industry, focusing on the production and distribution of specialty chemicals. The company offers a wide range of products, including nitrile and guanidine derivatives, which are used in various applications such as agriculture, pharmaceuticals, and renewable energy. Headquartered in Trostberg, Germany, AlzChem has a strong foundation in the region but exports its products globally. The company's strategic positioning leverages its specialized product offerings and research capabilities, enabling it to serve niche markets with high-value solutions. AlzChem's history includes a rich legacy of chemical expertise and innovation that began at its founding.
Ticker
€ACT
Sector
Primary listing
XETRA
Employees
1,680
Headquarters
Website
AlzChem Group AG Metrics
BasicAdvanced
€1.6B
25.13
€6.28
0.58
€1.80
1.14%
Price and volume
Market cap
€1.6B
Beta
0.58
52-week high
€170.80
52-week low
€72.67
Average daily volume
3.6K
Dividend rate
€1.80
Financial strength
Current ratio
2.495
Quick ratio
1.519
Long term debt to equity
13.937
Total debt to equity
17.129
Dividend payout ratio (TTM)
28.66%
Interest coverage (TTM)
17.51%
Profitability
EBITDA (TTM)
113.549
Gross margin (TTM)
68.87%
Net profit margin (TTM)
10.84%
Operating margin (TTM)
15.62%
Effective tax rate (TTM)
27.64%
Revenue per employee (TTM)
€340,000
Management effectiveness
Return on assets (TTM)
10.19%
Return on equity (TTM)
27.33%
Valuation
Price to earnings (TTM)
25.131
Price to revenue (TTM)
2.724
Price to book
6.22
Price to tangible book (TTM)
6.3
Price to free cash flow (TTM)
40.653
Free cash flow yield (TTM)
2.46%
Free cash flow per share (TTM)
3.882
Dividend yield (TTM)
1.14%
Forward dividend yield
1.14%
Growth
Revenue change (TTM)
3.91%
Earnings per share change (TTM)
18.16%
3-year revenue growth (CAGR)
2.13%
10-year revenue growth (CAGR)
5.93%
3-year earnings per share growth (CAGR)
28.42%
10-year earnings per share growth (CAGR)
-7.64%
3-year dividend per share growth (CAGR)
25.99%
10-year dividend per share growth (CAGR)
-11.71%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for AlzChem Group AG stock?
AlzChem Group AG (ACT) has a market cap of €1.6B as of March 12, 2026.
What is the P/E ratio for AlzChem Group AG stock?
The price to earnings (P/E) ratio for AlzChem Group AG (ACT) stock is 25.13 as of March 12, 2026.
Does AlzChem Group AG stock pay dividends?
Yes, the AlzChem Group AG (ACT) stock pays dividends to shareholders. As of March 12, 2026, the dividend rate is €1.8 and the yield is 1.14%. AlzChem Group AG has a payout ratio of 28.66% on a trailing twelve-month basis.
When is the next AlzChem Group AG dividend payment date?
The next AlzChem Group AG (ACT) dividend payment is scheduled for May 08, 2026.
What is the beta indicator for AlzChem Group AG?
AlzChem Group AG (ACT) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.